Skip to main content
. 2012 Jan 16;40(4):960–964. doi: 10.3892/ijo.2012.1334

Figure 3.

Figure 3

Overall survival curves of patients treated with HIPEC therapy subdivided according to expression of MUC 2. The patients with MUC2-positive tumors had poorer prognosis than those with MUC2-negaitive counterparts.